Gynecologic Neoplasms Clinical Trial
Official title:
A Phase IB Combination Study of Rucaparib (CO-338) and Atezolizumab (MPDL3280A) in Participants With Advanced Gynecologic Cancers and Triple-Negative Breast Cancer
This is a Phase Ib, open-label, non-randomized study in patients with previously treated advanced ovarian or endometrial cancer (Part 1) and platinum-sensitive ovarian cancer or triple-negative breast cancer (TNBC) (Part 2) to investigate the dose, safety, pharmacokinetics, and preliminary efficacy of rucaparib in combination with atezolizumab. The study is conducted in 2 parts: a Dose-Finding Phase (Part 1) and a Dose-Expansion Phase (Part 2)
n/a
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02653469 -
Augmented Pulse Pressure Variation to Predict Fluid Responsiveness in Open Laparotomy
|
N/A | |
| Recruiting |
NCT05185947 -
Study of Intravenous and Intraperitoneal Paclitaxel and Oral Nilotinib for Peritoneal Carcinomatosis From Colorectal, Appendiceal, Small Bowel, Gastric, Cholangiocarcinoma, Breast, Ovarian, or Other Gynecologic Primary Cancer
|
Phase 2 | |
| Completed |
NCT02309944 -
Negative Pressure Wound Therapy in Obese Gynecologic Oncology Patients
|
N/A | |
| Withdrawn |
NCT00328757 -
Safety of Regular Diet as the First Meal in Patients Who Underwent Surgical Treatment for Gynecologic Cancer
|
Phase 3 | |
| Completed |
NCT02728830 -
A Study of Pembrolizumab on the Tumoral Immunoprofile of Gynecologic Cancers
|
Early Phase 1 | |
| Completed |
NCT02935530 -
Thromboprophylaxis After Surgery for Gynecologic Malignancy in China
|
Phase 3 | |
| Completed |
NCT02918461 -
Emerging From the Haze for Gynecologic Cancer Survivors
|
N/A | |
| Completed |
NCT02786524 -
Effect of Outpatient Symptom Management on Gynecologic Oncology Patients Receiving Chemotherapy
|
N/A | |
| Terminated |
NCT04493619 -
PLX2853 as a Single Agent in Advanced Gynecological Malignancies and in Combination With Carboplatin in Platinum-Resistant Epithelial Ovarian Cancer
|
Phase 1/Phase 2 |